Erasmus MC Cancer Institute

Recent papers from Erasmus MC Cancer Institute

1. Assessing the Operational Feasibility of Evolutionary Therapy in Metastatic Non-Small Cell Lung CancerJournal of Evolutionary Biology · 2026
2. Deep learning reveals prognostic information beyond AJCC stage in routine histopathology of early-stage melanoma: the population-based D-ESMEL study2026
3. Nivolumab consolidation in patients with double and triple hit high-grade B-cell lymphoma in complete metabolic remission after DA-EPOCH-RBlood Cancer Journal · 2026
4. Daring to be fallible: Reflections on culture, context and validity in programmatic assessmentMedical Education · 2026
5. Multi-modal data Integration for Metastatic Risk Prediction of AJCC Stage I/II Melanomas: Results from the Population-based Dutch Early-stage Melanoma Study (D-ESMEL)2026
6. Score interpretation thresholds for the European Organisation for Research and Treatment of Cancer thyroid cancer quality of life questionnaire (EORTC QLQ-THY34). An international prospective studyEndocrine · 2026
7. Microbiology Galaxy Lab: a community-driven gateway for reproducible and FAIR analysis of microbiological dataCommunications Biology · 2026
8. The healthcare experience of solid rare cancer patients and their healthcare professionals: quantitative results from the eortc qol rare cancer studyBMC Cancer · 2026
9. Zamtocabtagene autoleucel, a tandem CD20–CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 studyThe Lancet Oncology · 2026
10. Colorectal polyp size measurement comparing biopsy forceps with visual assessment during real-time colonoscopy: A prospective, multicenter, international studyWorld Journal of Gastrointestinal Endoscopy · 2026
11. Conference Proceedings for the First World CUP Alliance International Cancer of Unknown Primary Meeting 2025Anticancer Research · 2026
12. The Predictive Value of Gastrin for the Absorption of Erlotinib in Patients with Non-Small Cell Lung CancerClinical Pharmacokinetics · 2026
13. Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung CancerNew England Journal of Medicine · 2026
14. Multiple myeloma in the Netherlands: 35-year trends in incidence and survivalLeukemia · 2026
15. Clinical Outcomes of Patients With Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis: A Systematic Review and Meta-analysisTransplantation · 2026
16. Technical Complications and Salvage of Hepatic Artery Infusion PumpsAnnals of Surgery · 2026
17. Diagnostic Challenges in WHO Classification of Thymic Epithelial Tumors: The Clinical Value of an International Expert Pathology PanelEuropean Journal of Cancer · 2026
18. Prostate Imaging scoring systems: Indications, Interpretation, and Clinical Impact – A Narrative ReviewBJR|Open · 2026
19. Can We Omit Systematic Biopsies in Men with a Positive MRI During Repeat Biopsies for Active Surveillance for Prostate Cancer? Results from the PRIAS StudyEuropean Urology Open Science · 2026
20. [18F]FDG PET/CT-Derived Metabolic Characteristics and Tumour-Infiltrating Lymphocytes for Predicting Axillary Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast CancerCancers · 2026